Psylutions and the DEA
In August 2025, the psychedelics movement crossed an unprecedented threshold. The U.S. Drug Enforcement Administration (DEA) announced that it would forward a petition to reschedule psilocybin, the psychoactive compound found in “magic mushrooms”, to the Department of Health and Human Services (HHS) for scientific review. The post Psylutions and the DEA appeared first on Microdose.
External link. We are not responsible for the content.
Read more ↗More From Microdose (industry)
Ibogaine’s Momentum Is Real. So Is the Safety Gap Nobody’s Solving.
Recent reporting, has documented a string of serious adverse events at overseas psychedelic clinics such as cardiac d...
Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing
For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Ey...
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High
Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the...
Latest News
A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem?
Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that...
7 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. An independent media platform covering drugs, altered states & the culture surroundi...
Is “Gas Station Molly” the Next Big Grey Market Drug?
It feels like MDMA, skips the comedown, and it's already on head shop shelves. But is it legal? [...] Read More... Th...
Scent, Ritual, and Altered States
Kamila Aubre explores scent and the psychedelic experience
Inside the First Ayahuasca Forum Hosted by Indigenous Peoples
100 Indigenous leaders will gather at the World Ayahuasca Forum to set the terms for ayahuasca's future. [...] Read M...
Can Psilocybin Protect Skin Cells From Premature Aging?
PLUS Carlos Castaneda, foraging for psilocybin mushrooms, and Resilient Pharmaceuticals. [...] Read More... The post ...